# A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)

> **NCT00247364** · PHASE2 · COMPLETED · sponsor: **Sleep Health Centers** · enrollment: 20 (—)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Levetiracetam (Keppra)

## Key facts

- **NCT ID:** NCT00247364
- **Lead sponsor:** Sleep Health Centers
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 20 (—)
- **Last updated:** 2005-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247364, "A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00247364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*